Metraipolis › archive › dc_fef3e8b96337
Real-World Evidence of Neuropsychiatric Adverse Reactions to Isotretinoin: Insights from EudraVigilance (2005-2025) — Europe PMC PMID:41011124
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41011124
- DOI
- 10.3390/ph18091252
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T09:52:27.629Z
- SHA-256 of the archived text
16478498e66e21262a0a6633268484b58cd59678c7c4aebc9dc56ae1790c3956- Stable URL of this page
https://metraipolis.com/documento/dc_fef3e8b96337
How to cite
Real-World Evidence of Neuropsychiatric Adverse Reactions to Isotretinoin: Insights from EudraVigilance (2005-2025) — Europe PMC PMID:41011124 — Europe PMC (en), https://europepmc.org/article/MED/41011124 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fef3e8b96337 (Metraipolis archive dc_fef3e8b96337, sha256 16478498e66e21262a0a6633268484b58cd59678c7c4aebc9dc56ae1790c3956)
BibTeX
@misc{dcfef3e8b96337,
title = {Real-World Evidence of Neuropsychiatric Adverse Reactions to Isotretinoin: Insights from EudraVigilance (2005-2025) — Europe PMC PMID:41011124},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41011124},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fef3e8b96337; sha256 16478498e66e21262a0a6633268484b58cd59678c7c4aebc9dc56ae1790c3956},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41011124. Agents can read the archived copy with the MCP tool read_document.